-
-
-
-
-
-
-
Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
-
-
-
-
-
-
-
Interpace Biosciences (IDXG) Misses Q2 EPS by 41c
-
-
-
-
-
-
-
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
-
-
-
-
-
-
-
Interpace Biosciences Receives Nasdaq Deficiency Notice Due to Delayed Filing of Form 10-Q; No Immediate Impact on Listing
-
-
-
-
-
-
-
Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
-
-
-
-
-
-
-
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

